Edition:
India

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

17.90USD
19 Jan 2018
Change (% chg)

$0.09 (+0.51%)
Prev Close
$17.81
Open
$17.73
Day's High
$18.39
Day's Low
$17.28
Volume
86,145
Avg. Vol
124,994
52-wk High
$31.23
52-wk Low
$8.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 13.45 -0.263
Jun '17 14.13 -0.414
Mar '17 9.60 -2.089
FY 2016 Dec '16 0.00 -1.171
Sep '16 0.00 -0.686
Jun '16 0.00 -0.471
Mar '16 0.00 -0.552
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 9.75 12.00 7.50 --
Quarter Ending Jun-18 2 10.75 14.00 7.50 --
Year Ending Dec-18 4 76.48 93.62 58.00 --
Earnings (per share)
Quarter Ending Mar-18 2 -0.23 -0.18 -0.29 --
Quarter Ending Jun-18 2 -0.35 -0.15 -0.56 --
Year Ending Dec-18 4 -0.90 -0.22 -1.33 --
LT Growth Rate (%) 1 71.00 71.00 71.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta -- 0.90 0.89
Price to Sales (TTM) 78.42 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 10.29 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 12.27 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.78 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -142.68 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -525.72 -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) -526.50 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) -530.85 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) -530.85 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 912,500 948,195,516 855,725,041
Net Income/Employee (TTM) -4,843,962 111,561,295 100,665,186
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -35.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akcea Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 28.43 24.01 96 25
13 Week -- -- -- 36
26 Week -- -- -- 31
52 Week -- -- -- 12
YTD -- -- -- 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.18%
# of Holders: 75
Total Shares Held: 17,417,467
3 Mo. Net Change: -22,085
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 2
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.